Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial

Harriet Johansson, Debora Macis, Martino Oliva, Matteo Puntoni, Eva Blondeaux, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Irene Maria Briata, Tania Buttiron-Webber, Luca Boni, Matteo Lazzeroni, Davide Serrano, Livia Giordano, Maria Digennaro, Laura Cortesi, Francesco Millo, Katia Cagossi, Giuseppe Aprile, Fabio Falcini, Elisa Gallerani, Bernardo Bonanni, Andrea DeCensi

Open source

DOI: 10.1158/1078-0432.ccr-24-2987
Published: 2025-04-28
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-24-2987,
  title = {Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial},
  author = {Harriet Johansson and Debora Macis and Martino Oliva and Matteo Puntoni and Eva Blondeaux and Aliana Guerrieri-Gonzaga and Valentina Aristarco and Irene Maria Briata and Tania Buttiron-Webber and Luca Boni and Matteo Lazzeroni and Davide Serrano and Livia Giordano and Maria Digennaro and Laura Cortesi and Francesco Millo and Katia Cagossi and Giuseppe Aprile and Fabio Falcini and Elisa Gallerani and Bernardo Bonanni and Andrea DeCensi},
  year = {2025},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-24-2987},
  url = {https://doi.org/10.1158/1078-0432.ccr-24-2987}
}

RIS

TY  - JOUR
TI  - Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
AU  - Harriet Johansson
AU  - Debora Macis
AU  - Martino Oliva
AU  - Matteo Puntoni
AU  - Eva Blondeaux
AU  - Aliana Guerrieri-Gonzaga
AU  - Valentina Aristarco
AU  - Irene Maria Briata
AU  - Tania Buttiron-Webber
AU  - Luca Boni
AU  - Matteo Lazzeroni
AU  - Davide Serrano
AU  - Livia Giordano
AU  - Maria Digennaro
AU  - Laura Cortesi
AU  - Francesco Millo
AU  - Katia Cagossi
AU  - Giuseppe Aprile
AU  - Fabio Falcini
AU  - Elisa Gallerani
AU  - Bernardo Bonanni
AU  - Andrea DeCensi
PY  - 2025
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-24-2987
UR  - https://doi.org/10.1158/1078-0432.ccr-24-2987
ER  -

APA

Johansson, H., Macis, D., Oliva, M., Puntoni, M., Blondeaux, E., Guerrieri-Gonzaga, A., Aristarco, V., Briata, I. M., Buttiron-Webber, T., Boni, L., Lazzeroni, M., Serrano, D., Giordano, L., Digennaro, M., Cortesi, L., Millo, F., Cagossi, K., Aprile, G., Falcini, F., Gallerani, E., Bonanni, B., & DeCensi, A. (2025). Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-2987

Source records

crossref · retrieved 2026-09-27T13:22:16.700Z